Eterna Therapeutics sets 2025 annual meeting for May 1; shareholder proposals due Feb 23

Ernexa Therapeutics Inc.

Annual meeting date: May 1, 2025; over 30 days before one-year anniversary of 2024 meeting.
Stockholder proposals and director nominations must be received by Feb 23, 2025.
Rule 14a-8 proposals also due Feb 23, 2025; submissions to Cambridge, MA office.

item 5.08

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-006446

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.